tm
Seeing Is Believing
tm
Seeing Is Believing
TCRX is currently covered by 2 analysts with an average price target of $10.83. This is a potential upside of $8.2 (311.79%) from yesterday's end of day stock price of $2.63.
Tscan Therapeutics's activity chart (see below) currently has 1 price targets and 15 ratings on display. The stock rating distribution of TCRX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 96 days.
Highest price target for TCRX is $15, Lowest price target is $10, average price target is $10.83.
Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 11-Dec-2024. First documented stock forecast 17-Dec-2021.
Currently out of the existing stock ratings of TCRX, 13 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$15
$12.23 (441.52%)
$15
1 months 3 days ago
(11-Dec-2024)
0/10 (0%)
$12.26 (447.45%)
Buy
$10
$7.23 (261.01%)
$10
5 months 1 days ago
(13-Aug-2024)
2/4 (50%)
$4.14 (70.65%)
192
What is TCRX (Tscan Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on TCRX (Tscan Therapeutics) with a proven track record?
Which analyst has the current lower performing score on TCRX (Tscan Therapeutics) with a proven track record?
Which analyst has the most public recommendations on TCRX (Tscan Therapeutics)?
Which analyst is the currently most bullish on TCRX (Tscan Therapeutics)?
Which analyst is the currently most reserved on TCRX (Tscan Therapeutics)?
